Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Andrea Luciani, Antonio Marra, Luca Toschi, Diego Cortinovis, Sergio Fava, Virginio Filipazzi, Alessandro Tuzi, Giulio Cerea, Sabrina Rossi, Vittorio Perfetti, Antonio Rossi, Laura Giannetta, Luca Sala, Giovanna Finocchiaro, Elio Gregory Pizzutilo, Stephana Carelli, Francesco Agustoni, Massimiliano Cergnul, Sabrina Zonato, Salvatore SienaPaolo Bidoli, Daris Ferrari

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study'. Together they form a unique fingerprint.

Medicine & Life Sciences